EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry

Jean Oak iD, Felipe Magalhaes Furtado, Katherine A Devitt iD, Pedro Horna, Jonathan R Fromm, Lianqun Qiu iD, Andrea Illingworth, Jolene Cardinali, Wolfgang Kern, Ahmad Al-Attar, Min Shi

Cytometry Part B: Clinical Cytometry · 2025

DOI: 10.1002/cyto.b.22258 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2025. Verfasst von Jean Oak und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Flow Cytometry, Immunophenotyping, Lymphoma, T-Cell, T-Lymphocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diagnosis of T‐cell neoplasms remains one of the most challenging areas in hematopathology due to the immunophenotypic heterogeneity and subtle aberrancies often present in these entities. This “Best Practice” manuscript provides a practical framework for laboratories to design, validate, and interpret immunophenotyping studies of immature and mature T‐cell neoplasms. We outline the utility of key antigens in the screening and classification of T‐cell lymphomas/leukemia including TRBC1 and TRBC2. Analytical strategies using the “difference from normal” method and template‐based gating are discussed, along with validation considerations aligned with CLSI H62 guidelines. By integrating these principles into laboratory workflows, this manuscript aims to standardize and improve the assessment of T‐cell neoplasms across diverse clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryImmunophenotypingLymphoma, T-CellT-LymphocytesHumans

Stichwörter der Autor:innen

Assay validationDifference‐from‐normal analysisImmunophenotypingT cell neoplasms

Autor:innen und Institutionen

  • Department of Pathology, Stanford University, Stanford, California, USA.
  • Hematology Department, Sabin Diagnostico e Saude, Brasília, Brazil.
  • Oncohematology Department, Hospital da Criança de Brasília, Brasília, Brazil.
  • Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.
  • Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Jean Oak, Katherine A Devitt, Lianqun Qiu

Zitieren

APA

Oak, J., Furtado, F. M., Devitt, K. A., Horna, P., Fromm, J. R., Qiu, L., Illingworth, A., Cardinali, J., Kern, W., Al-Attar, A., & Shi, M. (2025). A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22258

Vancouver

Oak J, Furtado FM, Devitt KA, Horna P, Fromm JR, Qiu L, et al. A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry. Cytometry Part B: Clinical Cytometry. 2025. doi:10.1002/cyto.b.22258

BibTeX
@article{Oak2025,
  author = {Oak, Jean and Furtado, Felipe Magalhaes and Devitt, Katherine A and Horna, Pedro and Fromm, Jonathan R and Qiu, Lianqun and Illingworth, Andrea and Cardinali, Jolene and Kern, Wolfgang and Al-Attar, Ahmad and Shi, Min},
  title = {A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2025},
  doi = {10.1002/cyto.b.22258}
}
Kostenlos starten →